PRICE T ROWE ASSOCIATES INC /MD/

Position in GILD — Gilead Sciences, Inc.

CIK 80255 BALTIMORE, MD

Back to GILD Full portfolio

Position in GILD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,658,198,811

+$258,465,284 QoQ

Shares Held

26,248,108

-5.2% QoQ

Ownership

2.11%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 97.61282222703443.ToString("F0")% Shared 0.ToString("F0")% None 2.387177772965579.ToString("F0")%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $32,740,779,918 across 15 Drug Manufacturers - General names. GILD ranks #4 (11.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	13,992,224	$12,869,627,867
2	JNJ	Johnson & Johnson	16,491,133	$4,031,092,550
3	AZN	Astrazeneca PLC	19,489,220	$3,843,663,968
4	GILD	Gilead Sciences, Inc. This page	26,248,108	$3,658,198,811
5	ABBV	AbbVie Inc.	13,003,989	$2,828,237,567
6	MRK	Merck & Co., Inc.	23,042,842	$2,771,823,463
7	AMGN	Amgen Inc	1,867,189	$656,970,449
8	BMY	Bristol Myers Squibb Co	10,250,238	$621,676,934

All Filings in GILD

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,658,198,811	26,248,108	-5.2%	Shares	Defined	2026-05-15
2025-12-31	$3,399,733,527	27,698,660	+4.5%	Shares	Sole	2026-02-17
2025-09-30	$2,941,876,401	26,503,391	+12.4%	Shares	Sole	2025-11-14
2025-06-30	$2,615,056,542	23,586,692	+60.4%	Shares	Sole	2025-08-14
2025-03-31	$1,647,482,691	14,703,103	+314.6%	Shares	Sole	2025-05-14
2024-12-31	$327,610,618	3,546,721	+5.9%	Shares	Sole	2025-02-14
2024-09-30	$280,712,501	3,348,193	+17.7%	Shares	Sole	2024-11-14
2024-06-30	$195,224,814	2,845,428	+14.2%	Shares	Sole	2024-08-14
2024-03-31	$182,576,649	2,492,514	-11.7%	Shares	Sole	2024-05-15
2023-12-31	$228,569,714	2,821,500	+24.3%	Shares	Sole	2024-02-16
2023-09-30	$170,153,217	2,270,526	-27.3%	Shares	Sole	2023-11-14
2023-06-30	$240,585,179	3,121,645	+26.0%	Shares	Sole	2023-08-14
2023-03-31	$205,549,379	2,477,394	+2.8%	Shares	Sole	2023-05-15
2022-12-31	$206,901,761	2,410,038	+45.8%	Shares	Defined	2023-02-14
2022-09-30	$101,976,900	1,653,054	-19.6%	Shares	Sole	2022-11-14
2022-06-30	$127,161,156	2,057,291	-17.8%	Shares	Sole	2022-08-15
2022-03-31	$148,726,362	2,501,705	-8.4%	Shares	Sole	2022-05-16
2021-12-31	$198,216,296	2,729,876	-23.9%	Shares	Sole	2022-02-14
2021-09-30	$250,403,239	3,584,871	-31.5%	Shares	Sole	2021-11-15
2021-06-30	$360,446,568	5,234,484	-3.2%	Shares	Sole	2021-08-16
2021-03-31	$349,502,882	5,407,750	-15.6%	Shares	Sole	2021-05-17
2020-12-31	$373,490,877	6,410,760	-20.7%	Shares	Sole	2021-02-16
2020-09-30	$510,707,330	8,082,091	-8.6%	Shares	Sole	2020-11-16
2020-06-30	$680,656,403	8,846,587	-20.2%	Shares	Sole	2020-08-14
2020-03-31	$828,375,114	11,080,459	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.